The company’s gross profit totaled $41.5 million, up from 2012’s $38 million. In the first six months of the year, Exactech’s revenue has increased from $113.8 million to $119.9 million, or 5 percent.
So far this year, knee, extremity and hip implant revenue all decreased. However, biologics and spine revenue jumped 6 percent to $12.9 million.
More Articles on Devices:
8 New Spine, Orthopedic Device Launches & Releases
Ceiling-Mounted CT Device Receives FDA Market Approval
Dr. Donald Gajewski Develops IDEO Device to Help Injured Soldiers Walk, Run Again
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
